Meeting
2023 ASCO Annual Meeting
Prevalence of germline variants in patients with pancreatic neuroendocrine tumors.
Authors
Chirayu Mohindroo
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
Chirayu Mohindroo , Seyda Baydogan , Parul Agarwal , Dan Laheru , Robin Wright , Laura Prakash , Maureen E Mork , Alison Klein , Jess Maxwell , Matthew H. G. Katz , Arvind Dasari , Michael Paul Kim , Jin He , Florencia McAllister , Ana De Jesus-Acosta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4135)
DOI
10.1200/JCO.2023.41.16_suppl.4135
Abstract #
4135
Poster Bd #
456
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
DNA damage response and repair (DDR) gene mutations and correlation with tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC).
First Author: Hirva Mamdani
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2024 ASCO Annual Meeting
Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.
First Author: Murtaza Ahmed
Poster
2023 ASCO Annual Meeting
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
First Author: Daniel Walden